Modulation of apomorphine-induced climbing behavior by estradiol

Area of Science:

• Neuroscience
• Pharmacology
• Endocrinology

Background:

• Estrogen, a key hormone, influences neurotransmitter systems.
• Dopamine pathways are implicated in motor behaviors.
• Apomorphine is a dopamine receptor agonist used to induce climbing behavior in rodents.

Purpose of the Study:

• To investigate the acute and chronic effects of estradiol benzoate on apomorphine-induced climbing behavior in female mice.
• To evaluate the utility of the mouse climbing model for assessing estrogen's antidopaminergic effects.

Main Methods:

• Intact female mice were administered estradiol benzoate (0.1 or 0.3 mg/kg, SC) acutely (3.5 or 24 hours) or chronically (3 consecutive days).
• Apomorphine was administered to induce climbing behavior.
• Climbing behavior was quantified by measuring maximum climbing time and climbing index.

Main Results:

• Acute estradiol benzoate administration did not significantly alter apomorphine-induced climbing behavior.
• Chronic estradiol benzoate treatment (0.1 mg/kg) significantly attenuated climbing behavior at 24 and 72 hours post-injection.
• These findings indicate a time-dependent effect of estradiol benzoate on dopamine-mediated behavior.

Conclusions:

• Chronic, but not acute, estradiol benzoate administration exhibits antidopaminergic effects in mice.
• The mouse climbing behavioral model is a sensitive tool for evaluating the antidopaminergic actions of estrogens.
• Estrogen's influence on dopaminergic systems can be modulated by treatment duration.